Patent US4459362A successfully refreshed from Google Patents.
US4459362A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Immunoassay of phospholipid, such as phosphatidyl choline, in fluids such as amniotic
Assignee: HANA BIOLOGICS Inc A CORP OF CA
•
Filing: 1982-09-29
•
Granted: 1984-07-10
•
Expires: 2002-09-29
Abstract
Abstract An immunologic assay for determining the presence of one or more phospholipids in a biological fluid. The method includes adding an ethanolic solution of diacylphosphatidylcholine or alkyltrimethylammonium halide and cholesterol to the biological fluid forming a macromolecular aggregate complex suspension. To the macromolecular aggregate complex solution is then added either an additional quantity of the biological fluid or a buffer reagent. The product of the reaction is then added to antibody molecules to the phospholipid and examined to determine the presence of the phospholipids. The method is particularly useful in determining the presence of phosphatidylglycerol in a sample of amniotic fluid.
Inventors
- 👤 Kenichi K. Yabusaki
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 06:18
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/92; Y; Y10; Y10S; Y10S436/00; Y10S436/811; Y10S436/815
Claims Analysis
Total Claims: 22
Claim 1
Independent Claim
87 words
A method of determining the presence of a phospholipid in a biological fluid comprising: A. adding an ethanolic solution of cholesterol and a member selected from the group consisting of diacylphosphatidylcholine and an alkyltrimethylammonium halide to the biological fluid forming a macromolecular aggregate complex suspension; B. adding the macromolecular aggregate complex solution to antibody molecules to the phospholipid in an aqueous buffered medium causing an agglutination reaction; and C. adding additional biological fluid in an amount as to enable a determination of the presence of the phospholipid.
Claim 2
Independent Claim
87 words
A method of determining the presence of a phospholipid in a biological fluid comprising: A. adding an ethanolic solution of cholesterol and a member selected from the group consisting of diacylphosphatidylcholine and an alkyltrimethylammonium halide to the biological fluid forming a macromolecular aggregate complex suspension; B. adding the macromolecular aggregate complex solution to antibody molecules to the phospholipid in an aqueous buffered medium causing an agglutination reaction; and C. adding additional biological fluid in an amount as to enable a determination of the presence of the phospholipid.
Claim 3
Independent Claim
102 words
A method of determining the presence of a phospholipid in a biological fluid comprising: A. adding an ethanolic solution of cholesterol and a member selected from the group consisting of diacylphosphatidylcholine and an alkyltrimethylammonium halide to the biological fluid forming a macromolecular aggregate complex suspension; B. adding the macromolecular aggregate complex solution to antibody molecules to the phospholipid in an aqueous buffered medium causing an agglutination reaction; and C. adding buffer reagent comprising a buffer and a member selected from the group consisting of diacylphosphatidylcholine and alkyltrimethylammonium halide in an amount as to enable a determination of the presence of the phospholipid.
Claim 4
Independent Claim
102 words
A method of determining the presence of a phospholipid in a biological fluid comprising: A. adding an ethanolic solution of cholesterol and a member selected from the group consisting of diacylphosphatidylcholine and an alkyltrimethylammonium halide to the biological fluid forming a macromolecular aggregate complex suspension; B. adding the macromolecular aggregate complex solution to antibody molecules to the phospholipid in an aqueous buffered medium causing an agglutination reaction; and C. adding buffer reagent comprising a buffer and a member selected from the group consisting of diacylphosphatidylcholine and alkyltrimethylammonium halide in an amount as to enable a determination of the presence of the phospholipid.
Claim 5
Independent Claim
24 words
The method of claims 1 or 2 wherein the phospholipid is a member from the group consisting of phosphatidylcholine, phosphatidylinositol, phosphatidylserine, phosphatidylethanolamine and phosphatidylglycerol.
Claim 6
Independent Claim
14 words
The method of claims 1 or 2 wherein the biological fluid comprises amniotic fluid.
Claim 7
Dependent Claim
10 words
The method of claim 4 wherein the phospholipid comprises phosphatidylglycerol.
Claim 8
Independent Claim
31 words
The method of claims 1 or 2 wherein sufficient diacylphosphatidylcholine and cholesterol are added to the biological fluid such that the phospholipid-containing macromolecular aggregates can be bound to the antibody molecules.
Claim 9
Independent Claim
33 words
The method of claims 1 or 2 wherein sufficient alkyltrimethylammonium halide and cholesterol are added to the biological fluid such that the phospholipid containing macromolecular aggregates can be bound to the antibody molecules.
Claim 10
Dependent Claim
11 words
The method of claim 2 wherein the buffer comprises sodium phosphate.
Claim 11
Dependent Claim
17 words
The method of claim 2 wherein the pH of the buffer reagent is approximately 5 to 7.
Claim 12
Dependent Claim
25 words
The method of claim 2 wherein the buffer reagent in the biological fluid containing solution is in a concentration of approximately 0.001 to 0.5 molar.
Claim 13
Dependent Claim
32 words
The method of claim 2 wherein the member selected from the group consisting of diacylphosphatidylcholine and alkyltrimethylammonium halide is present in the buffer reagent in a concentration of 1 to 200 mg/l.
Claim 14
Independent Claim
14 words
The method of claims 1 or 2 wherein the alkyltrimethylammonium halide is hexadecyltrimethylammonium bromide.
Claim 15
Independent Claim
109 words
A method of determining the presence of phosphatidylglycerol in a sample of amniotic fluid comprising: A. adding an ethanolic solution of cholesterol and a member selected from the group consisting of diacylphosphatidylcholine and alkyltrimethylammonium halide to a sample of amniotic fluid forming macromolecular aggregates of cholesterol, phosphatidylglycerol and a member selected from the group consisting of diacylphosphatidylcholine and alkyltrimethylammonium halide; B. adding additional amniotic fluid in an amount as to enable a determination of the presence of the phosphatidylglycerol; and C. forming an agglutination reaction by adding the phosphatidylglycerol macromolecular aggregate complex containing suspension to a known quantity of antibody molecules to the phosphatidylglycerol in a buffered aqueous medium.
Claim 16
Independent Claim
109 words
A method of determining the presence of phosphatidylglycerol in a sample of amniotic fluid comprising: A. adding an ethanolic solution of cholesterol and a member selected from the group consisting of diacylphosphatidylcholine and alkyltrimethylammonium halide to a sample of amniotic fluid forming macromolecular aggregates of cholesterol, phosphatidylglycerol and a member selected from the group consisting of diacylphosphatidylcholine and alkyltrimethylammonium halide; B. adding additional amniotic fluid in an amount as to enable a determination of the presence of the phosphatidylglycerol; and C. forming an agglutination reaction by adding the phosphatidylglycerol macromolecular aggregate complex containing suspension to a known quantity of antibody molecules to the phosphatidylglycerol in a buffered aqueous medium.
Claim 17
Independent Claim
124 words
A method of determining the presence of phosphatidylglycerol in a sample of amniotic fluid comprising: A. adding an ethanolic solution of cholesterol and a member selected from the group consisting of diacylphosphatidylcholine and alkyltrimethylammonium halide to a sample of amniotic fluid forming macromolecular aggregates of cholesterol, phosphatidylglycerol and a member selected from the group consisting of diacylphosphatidylcholine and alkyltrimethylammonium halide; B. adding buffer reagent comprising a buffer and a member selected from the group consisting of diacylphosphatidylcholine and alkyltrimethylammonium halide in an amount as to enable a determination of the presence of the phosphatidylglycerol; and C. forming an agglutination reaction by adding the phosphatidylglycerol macromolecular aggregate complex containing suspension to a known quantity of antibody molecules to the phosphatidylglycerol in a buffered aqueous medium.
Claim 18
Independent Claim
124 words
A method of determining the presence of phosphatidylglycerol in a sample of amniotic fluid comprising: A. adding an ethanolic solution of cholesterol and a member selected from the group consisting of diacylphosphatidylcholine and alkyltrimethylammonium halide to a sample of amniotic fluid forming macromolecular aggregates of cholesterol, phosphatidylglycerol and a member selected from the group consisting of diacylphosphatidylcholine and alkyltrimethylammonium halide; B. adding buffer reagent comprising a buffer and a member selected from the group consisting of diacylphosphatidylcholine and alkyltrimethylammonium halide in an amount as to enable a determination of the presence of the phosphatidylglycerol; and C. forming an agglutination reaction by adding the phosphatidylglycerol macromolecular aggregate complex containing suspension to a known quantity of antibody molecules to the phosphatidylglycerol in a buffered aqueous medium.
Claim 19
Independent Claim
17 words
The method of claims 1, 2, 13 or 14 wherein the complex solution further comprises sodium chloride.
Claim 20
Dependent Claim
21 words
The method of claim 15 wherein the sodium chloride is present in an amount between approximately 0.05 to 2.0 weight percent.
Claim 21
Independent Claim
17 words
The method of claims 1, 2, 13 or 14 wherein the diacylphosphatidylcholine comprises hen egg yolk lecithin.
Claim 22
Independent Claim
14 words
The method of claims 13 or 14 wherein the alkyltrimethylammonium halide is hexadecyltrimethylammonium bromide.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-07-10 | 1988-01-09 | 1988-07-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-07-10 | 1992-01-09 | 1992-07-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-07-10 | 1996-01-09 | 1996-07-10 | $7700.00 | Window Closed / Lapsed |